Skip to main content

Want a detailed portfolio tracker?

KING PHARMACEUTICALS (KG) Revenue (2024 - 2026)

KING PHARMACEUTICALS (KG) revenue from Jun 30, 2024 to Mar 31, 2026. The TTM KING PHARMACEUTICALS (KG) revenue is $39M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Quarterly Revenue

KING PHARMACEUTICALS (KG) Revenue CAGR table

PeriodCAGR
1 Year TTM+1604.95%

Annual Revenue change of KING PHARMACEUTICALS (KG)

YearRevenueChange
2026$10M-70.07%
2025$34M+784.42%
2024$3.85MN/A